• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Alchemie Group
  • BSE Code : 2975.0
  • ISIN : INE767A01016
473.60 -4 (-0.81%)
  • As on 13 Jul 2025 (EOD)
  • Today’s Low

    471.15
  • Today’s High

    488.00
  • Open

    475.70
  • Perv Close

    477.45
  • 52W Low

    312.00
  • 52W High

    635.00

Key Indicators

  • P/E(TTM)

    27.68

  • Mar.Cap (₹Cr.)

    4,354.04

  • Div & Yield %

    0.21

  • Book Value(₹)

    136.18

  • Debt-Equity Ratio

    -0.81

  • AGM Date

    11-Jul-2025

  • EPS

    17.11

  • P/E Ratio

    27.68

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    4,354.04

  • RONW (%)

    13.87

  • ROCE (%)

    14.97

Score Board

  • Equity (₹ in Cr.)

    91.94

  • BV (₹)

    136.20

  • Sales( ₹ in Cr.)

    2,173.65

  • NP (in Cr.)

    157.31

  • NP Var(%)

    11.0

  • Div%

    10.0

  • CPS (₹)

    22.30

  • EPS (₹)

    17.10

  • Traded Value (₹ in Lakhs)

    4,354.04

  • 52 Week High

    635.00

  • 52 Week Low

    312.00

  • Price BSE

    474.0

  • Price NSE

    474.00

  • Market Capital( in Cr.)

    4,354.04

  • P/C Ratio

    21.20

  • P/E Ratio

    27.70

  • Price Vs.BV

    17.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Other Income 4.18 2.23 4.77 9.69 9.44 6.28
Stock Adjustments -26.77 6.72 77.94 9.08 53.94 -19.05
Total Income 2,244.32 2,506.92 2,333.88 1,933.66 1,698.30 1,441.48
EXPENDITURE :            
Raw Materials 1,476.42 1,723.25 1,558.47 1,148.99 1,099.82 945.98
Power and Fuel Cost 151.64 153.45 126.05 95.64 101.04 82.14
Employee Cost 70.20 64.30 57.17 55.60 52.65 47.23
Other Manufacturing Expenses 191.24 182.71 171.26 138.99 122.62 103.91
Selling and Administration Expenses 73.95 89.25 89.75 76.70 59.39 50.37
Miscellaneous Expenses 7.52 5.68 5.24 6.72 5.40 2.83
Employee Benefit Expenses 70.20 64.30 57.17 55.60 52.65 47.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,970.96 2,218.64 2,007.95 1,522.64 1,440.92 1,232.46
Operating Profit 273.36 288.28 325.94 411.02 257.38 209.02
Interest 33.21 36.18 23.05 25.71 35.74 41.00
Gross Profit 240.15 252.10 302.89 385.31 221.64 168.02
Depreciation 47.67 47.29 47.39 47.60 46.67 40.39
Profit Before Tax 192.48 204.81 255.50 337.71 174.97 127.63
Current Tax 49.60 53.25 65.50 84.50 49.55 31.92
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.00 -1.25 -5.00 -4.50 -10.25 8.45
Reported Net Profit 141.88 152.81 195.00 257.71 135.67 87.26
Extraordinary Items 0.00 0.00 0.00 0.17 6.35 2.54
Adjusted Net Profit 141.88 152.81 195.00 257.54 129.32 84.72
Adjustment below Net Profit -13.32 0.00 -51.64 -69.90 -26.90 -0.48
P & L Balance brought forward 947.13 818.86 704.26 565.52 475.07 399.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 23.38 24.54 28.76 49.07 18.32 11.06
P & L Balance carried down 1,052.31 947.13 818.86 704.26 565.52 475.07
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 25.00 20.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 2.50 2.00 1.00
Earnings Per Share-Unit Curr 15.43 16.50 21.06 27.65 58.23 37.00
Earnings Per Share(Adj)-Unit Curr 15.43 16.50 21.06 27.65 14.56 9.25
Book Value 127.83 120.34 104.99 92.23 266.86 219.90
Book Value(Adj)-Unit Curr 127.83 120.34 104.99 92.23 66.72 54.97

Shareholding Pattern

  • Promoter Group

    55.48%

  • Public Share Holding

    44.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,969,465 9.83 8,969,465 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,882,932 41.51 37,882,932 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 3,780,783 4.14 3,780,783 4
Others 0 0.00 0 0
Sub Total 50,633,180 55.48 50,633,180 41
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 16 0.00 16 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,051,977 2.25 2,051,977 80
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 70,214 0.08 70,214 1
Mutual Funds / UTI 7,990,515 8.75 7,990,515 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 796,747 0.87 796,747 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,909,469 11.95 10,909,469 96
2] Non Institution
Bodies Corporate 878,726 0.96 878,725 480
Clearing Members 750 0.00 750 1
Directors of their Relatives 4,953,290 5.43 4,951,090 8
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 636,591 0.70 636,591 2,158
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 641,314 0.70 641,314 3,716
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,432,306 4.86 4,400,306 66
Individuals holding nominal share capital up to Rs. 1 lakh 17,024,434 18.65 16,455,694 163,143
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,115 0.00 1,115 5
Others 1,005,397 1.10 1,005,397 13
Sub Total 29,727,351 32.57 29,124,410 169,624
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 91,270,000 100.00 90,667,059 169,761

Company Background

Aarti Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarti Drugs Ltd
  • BSE Code : 2975.0
  • ISIN : INE767A01016
  • Incorporation Year

    1984

  • Registered Office

    Plot No N-198 MIDC Tarapur
    Pamtembhi Village Palghar Tal, Thane,
    Maharashtra-401506

  • Telephone

    91-22-24072249

  • FAX

    91-22-24073462/24070144

  • Chairman

    C V Gogri

  • Managing Director

    Rashesh C Gogri

  • Company Secretary

    Rushikesh Deole

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Drugs 473.60 2,271.09 2,266.91 27.68 13.65
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10